Barrett's esophagus: Natural history

Annals of the New York Academy of Sciences

Volumn 1232, Issue 1, 2011, Pages 292-308

  Appelman, Henry D ^a   Umar, Asad ^b   Orlando, Roy C ^c   Sontag, Stephen J ^d   Nandurkar, Sanjay ^e   El Zimaity, Hala ^f   Lanas, Angel ^g   Parise, Paolo ^h   Lambert, René ⁱ   Shields, Helen M ^j  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BOX HILL HOSPITAL   (Australia)

^f TORONTO GENERAL HOSPITAL   (Canada)

^g UNIVERSITY OF ZARAGOZA   (Spain)

^h Department of General Surgery IV   (Italy)

ⁱ INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

more..

Author keywords

Adenocarcinoma; Barrett's esophagus; Bile salts; Bimodal protocol; Biopsy protocol; Cag A postive strain; CDX2; Dilated intercellular spaces; Endoscopic grading system; Endoscopic mucosal resection; Esophageal metaplasia; Gastric atrophy; GERD; H. pylori; High resolution endoscopy; High grade dysplasia; Interobserver reproducibility; Laparoscopic surgery; Metaplasia; Narrow band imaging; Radiofrequency ablation; Reflux; Trimodal technology

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II; PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; ARTICLE; AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; BIOPSY; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CELL TRANSFORMATION; CHROMOENDOSCOPY; DRUG EFFICACY; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTION; HUMAN; MAGNIFYING ENDOSCOPY; NARROW BAND IMAGING; PHENOTYPE; PRACTICE GUIDELINE; PREVALENCE; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; SENSITIVITY AND SPECIFICITY; STOMACH ATROPHY; STOMACH DISEASE;

HELICOBACTER PYLORI;

EID: 80053219268     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06057.x     Document Type: Article

References (57)

1. Kahrilas, P.J. & J.E. Pandolfino 2002. Gastroesophageal reflux disease and its complications, including Barrett's metaplasia. In Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. Chapter 33. M. Feldman, L.S. Friedman & M.H. Sleisenter, Eds.: 616. Saunders. Philadelphia .
2. Spechler, S.J., R.C. Fitzgerald, G.A. Prasad & K.K. Wang 2010. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterol 138: 854-859.
3. Society of Thoracic Surgeons, website, .2010.
4. Blot, W.J. & J.F. Fraumeni, Jr. 1987. Trends in esophageal cancer mortality among US blacks and whites. Am. J. Public Health 77: 296-298.
5. Polednak, A.P. 2003. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int. J. Cancer 105: 98-100.
6. Camilleri, M., D. Dubois, B. Coulie, et al 2005. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin. Gastroenterol. Hepatol. 3: 543-552.
7. Hayeck, T.J., C.Y. Kong, S.J. Spechler, et al The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis. Esophagus, 23: 451-457.
8. Gerson, L.B., R. Edson, P.W. Lavori & G. Triadafilopoulos 2001. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am. J. Gastroenterol. 96: 2005-2012.
9. Ronkainen, J., P. Aro, T. Storskrubb, et al 2005. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129: 1825-1831.
10. Oberg, S., J. Johansson, J. Wenner & B. Walther 2002. Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann. Surg. 235: 338-345.
11. Su, Y., X. Chen, M. Klein, et al 2004. Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab. Invest. 84: 753-765.
12. Souza, R.F., K. Krishnan & S.T. Spechler 2008. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G211-G218.
13. Alvaro-Villegas, J.C., S. Sobrino-Cossio, A. Hernandez-Guerrero, et al Dilated intercellular spaces in subtypes of gastroesophagic reflux disease. Rev. Esp. Enferm. Dig. 102: 302-307.
14. Abela, J.-E., J.J. Going, J.F. Mackenzie, et al 2008. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Am. J. Gastroenterol. 103: 850-855.
15. Ajumobi, A., K. Bahjri, C. Jackson & R. Griffin 2010. Surveillance in Barrett's esophagus: an audit of practice. Dig. Dis. Sci. 55: 1615-1621.
16. Komanduri, S., G. Swanson, L. Keefer & S. Jakate 2009. Use of a new jumbo forceps improves tissue acquisition of Barrett's esophagus surveillance biopsies. Gastrointest. Endosc. 70: 1072-1078.
17. Reid, B.J., P.L. Blount, Z. Feng & D.S. Levine 2000. Optimizing endoscopic biopsy detection of early cancer in Barrett's high-grade dysplasia. Am. J. Gastroenterol. 95: 3089-3096.
18. Manath, J., V. Subramanian, J. Hawkey & K. Ragunath 2010. Narrow band imaging for characterization of high-grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta analysis. Endoscopy 42: 351-359.
19. Blaser, M.J. 1999. Hypothesis: the changing relationships ofHelicobacter pyloriand humans: implications for health and disease. J Infect Dis. 179: 1523-1530.
20. Abe, Y., K. Iijima, T. Koike, et al. 2009. Barrett's esophagus is characterized by the absence ofHelicobacter pyloriinfection and high levels of serum pepsinogen I concentration in Japan. J. Gastroenterol. Hepatol. 24: 129-134.
21. Kimura, K. 1973. Chronological changes of atrophic gastritis. Nippon Shokakibyo Gakkai Zasshi. 70: 307-315.
22. Kim, D.H., G.H. Kim, J.Y. Kim, et al. 2007. Endoscopic grading of atrophic gastritis is inversely associated with gastroesophageal reflux and gastropharyngeal reflux. Korean J. Intern. Med. 22: 231-236.
23. El-Zimaity, H.M., H. Ota, D.Y. Graham, et al 2002. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 94: 1428-1436.
24. Rokkas T., D. Pistiolas, P. Sechopoulos, et al 2007. Relationship betweenHelicobacter pyloriinfection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol. Hepatol. 5: 1413-1417.
25. Wang, C., Y. Yuan & R.H. Hunt 2009. Helicobacter pyloriinfection and Barrett's esophagus: a systematic review and meta-analysis. Am. J. Gastroenterol. 104: 492-500.
26. Mccoll, K.E. 2007. Helicobacter pyloriand oesophageal cancer-not always protective. Gut. 56: 457-459.
27. Axon, A.T. 2004. Personal view: to treat or not to treat? Helicobacter pyloriand gastro-oesophageal reflux disease-an alternative hypothesis. Aliment. Pharmacol. Ther. 19: 253-261.
28. Holtmann, G., C. Cain & P. Malfertheiner 1999. GastricHelicobacter pyloriinfection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 117: 11-16.
29. Yachida, S., D. Saito, T. Kozu, et al 2001. Endoscopically demonstrable esophageal changes afterHelicobacter pylorieradication in patients with gastric disease. J. Gastroenterol. Hepatol. 16: 1346-1352.
30. Peters, F.T., E.J. Kuipers, S. Ganesh, et al 1999. The influence ofHelicobacter pylorion oesophageal acid exposure in GERD during acid suppressive therapy. Aliment. Pharmacol. Ther. 13: 921-926.
31. Raghunath, A.S., A.P. Hungin, D. Wooff & S. Childs 2004. Systematic review: the effect ofHelicobacter pyloriand its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment. Pharmacol. Ther. 20: 733-744.
32. Kuipers, E.J., G.F. Nelis, E.C. Klinkenberg-Knol, et al 2004. Cure ofHelicobacter pyloriinfection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut. 53: 12-20.
33. Wang, K.K. & R.E. Sampliner 2008. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 103: 788-797.
34. Spechler, S.J., A.H. Robbins, et al 1984. Adenocarcinoma and Barrett'esophagus: an overrated risk Gastroenterology 87: 927-933.
35. Cameron, A.J., B.J. Ott, et al 1985. The incindence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N. Engl. J. Med. 313: 857-859.
36. Weston, A.P., A.S. Badr, et al 1999. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am. J. Gastroenterol. 94: 3413-3419.
37. Hage, M., D. Siersema, et al 2004. Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12, 7 years. Scand. J. Gastroenterol. 12: 1175-1179.
38. Peters, F.T., S. Ganesh, et al 1999. Endoscopic regression of Barrett's esophagus during omeprazole treatment: a randomized double-blind study. Gut. 45: 489-494.
39. Gurski, R., J.H. Peters, et al 2003. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J. Am. Coll. Surg. 196: 706-712.
40. Csendes, A., I. Braghetto, et al 2009. Late results of surgical treatments of 125 patients with short-segment Barrett's esophagus. Arch. Surg. 144: 921-927.
41. Hofstetter, W.L., J.H. Peters, et al 2001. Long-term outcome of anti-reflux surgery in patients with Barrett's esophagus. Ann. Surg. 234: 532-539.
42. Parrilla, P., L.F. Martinez de Haro, et al 2003. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann. Surg. 237: 291-298.
43. Rossi, M., M. Barreca, et al 2006. Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus. A prospective study. Ann. Surg. 243: 58-63.
44. Martinez de Haro, L., A. Ortiz, et al 2001. Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesphageal reflux. Ann. Surg. 233: 34-38.
45. Todd, J.A., K.K. Basu, et al 2005. Normalisation of oesophageal pH does not guatantee control of duodenogastro-esophageal reflux in Barrett's esophagus. Aliment. Pharmacol. Ther. 21: 969-975.
46. Chang, E.Y., C.D. Morris, et al 2007. The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett's esophagus. Ann. Surg. 246: 11-21.
47. Corey, K.E., S.M. Schmitz, et al 2003. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am. J. Gastroenterol. 98: 2390-2394.
48. Lambert, R. & P. Hainaut 2007. Esophageal cancer: the precursors (Part II). Endoscopy 39: 659-664.
49. Singh, R., G.K. Anagnostopoulos, K. Yao, et al 2008. Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology. Endoscopy 40: 457-463.
50. Mannath, J., V. Subramanian, C.J. Hawkey, et al 2010. Narrow band imaging for characterization of high-grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy 42: 351-359.
51. Kara, M.A., F.P. Peters, P. Fockens, et al 2006. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest. Endosc. 64: 176-185.
52. Curvers, W.L., L.A. Herrero, M.B. Wallace, et al 2010. Endoscopic tri-modal imaging is more effective than standard endoscopy in targeting early-stage neoplasia in Barrett's esophagus. Gastroenterology [Epub ahead of print.
53. Maru, D.M. 2009. Barrett's esophagus: diagnostic challenges and recent developments. Ann. Diag. Path. 13: 212-221.
54. Reid, B.J., D.S. Levine, G. Longton, et al 2000. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am. J. Gastroenterol. 95: 1669-1676.
55. Schnell, T.G., S.J. Sontag, G. Chejfec, et al 2001. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120: 1607-1619.
56. Ell, C., A. May, L. Grossner, et al 2000. Endoscopic mucosal resection for early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118: 670-677.
57. Shaheen, N.J., P. Sharma, B.F. Overholt, et al 2009. Radiofrequency ablation in Barrett's esophagus with dysplasia. N. Engl. J. Med. 360: 2277-2288.